In those suffering from rheumatoid arthritis, a condition where depression-related symptoms are linked to high IL-6 levels, treatment with sirukumab significantly improved the reduction of depressive symptoms by the eighth week [309]. This evidence concerns the gene IL6 and depressive symptom measurement.